This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Diabetes Mellitus, Insulin Action and Resistance
Organizer(s): Mary-Elizabeth Patti and David E. Moller
Date: January 22 - 27, 2008
Location: Beaver Run Resort, Breckenridge, CO, USA
Part of the Translational Medicine Series, Sponsored by Pfizer Global Research & Development
Summary of Meeting:
The incidence of type 2 diabetes is increasing worldwide at an alarming rate – mandating intensive efforts to improve our understanding of diabetes pathophysiology, improve options for therapy, and most importantly, to initiate strategies for disease prevention in high-risk groups. This meeting will focus on recent advances in our understanding of the molecular pathogenesis of insulin resistance, diabetes, and related syndromes, with particular emphasis on (1) multi-system nature of diabetes pathophysiology, (2) genetic basis of insulin resistance and diabetes risk, (3) potential links between epigenetic modulation of gene expression and diabetes risk related to “environmental” mechanisms, (4) pathways linking obesity, inflammation, and diabetes risk, and (5) new molecular mechanisms of insulin resistance. Moreover, the meeting will highlight novel pharmacologic targets for diabetes therapy. A key goal of the meeting will also be to facilitate collaborative interactions between basic scientists and translational clinical scientists focused on prevention and treatment of insulin resistance and diabetes.
Scholarship Deadline: September 24 2007
Discounted Abstract Deadline: September 24 2007
Abstract Deadline: October 25 2007
Discounted Registration Deadline: November 26 2007
We gratefully acknowledge additional support for this conference from:
Cell Signaling Technology, Inc.Educational grant from Lilly USA, LLCMerck & Co., Inc.Pfizer Global Research & DevelopmentSeahorse Bioscience, Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Educational grant from Lilly USA, LLC
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 5R13DK076500-02
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found